Diagnosis and treatment of diminished ovarian reserve in assisted reproductive technology cycles of women up to age 40 years: the role of insurance mandates-Reference-Cited by-同舟云学术

Diagnosis and treatment of diminished ovarian reserve in assisted reproductive technology cycles of women up to age 40 years: the role of insurance mandates

Published:2013-02 Issue:2 Volume:99 Page:382-388.e7
ISSN:0015-0282
Container-title:Fertility and Sterility
language:en
Short-container-title:Fertility and Sterility

Author:

Butts Samantha F.,Ratcliffe Sarah,Dokras Anuja,Seifer David B.

Funder

National Institute of Environmental Health Sciences

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Reproductive Medicine

Reference18 articles.

1. Correlation of telomere length and telomerase activity with occult ovarian insufficiency;Butts;J Clin Endocrinol Metab,2009

2. The value of basal and/or stimulated serum gonadotropin levels in prediction of stimulation response and in vitro fertilization outcome;Muasher;Fertil Steril,1988

3. Basal follicle-stimulating hormone level is a better predictor of in vitro fertilization performance than age;Toner;Fertil Steril,1991

4. A moderately elevated day 3 FSH concentration has limited predictive value, especially in younger women;Esposito;Hum Reprod,2002

5. Insurance mandates, embryo transfer, outcomes—the link is tenuous;Banks;Fertil Steril,2010

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MicroRNA profiling reveals effects of Erzhi Tiangui granules on kidney deficiency diminished ovarian reserve: A randomized trial;Medicine;2023-04-25

2. Impact of comprehensive state insurance mandates on in vitro fertilization utilization, embryo transfer practices, and outcomes in the United States;American Journal of Obstetrics and Gynecology;2022-07

3. Effect of acupuncture for diminished ovarian reserve: study protocol for a randomized controlled trial;Trials;2021-10-19

4. Maternal serum concentration of anti-Müllerian hormone is a better predictor than basal follicle stimulating hormone of successful blastocysts development during IVF treatment;PLOS ONE;2020-10-12

5. State Insurance Mandates and Multiple Birth Rates After In Vitro Fertilization;Obstetrics & Gynecology;2016-12